Impact of depression on HIV outcomes in the HAART era

被引：87
作者：
Hartzell, Joshua D. [1 ,2 ]
Janke, Igor E. [3 ]
Weintrob, Amy C. [1 ,2 ]
机构：
[1] Walter Reed Army Med Ctr, Infect Dis Serv, Dept Med, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Walter Reed Army Med Ctr, Dept Psychiat, Washington, DC 20307 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 62卷 / 02期
关键词：
AIDS; mental health; psychiatric;
D O I：
10.1093/jac/dkn193
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Highly active antiretroviral therapy (HAART) has significantly decreased the morbidity and mortality of persons infected with HIV. The extent of the benefits, however, is not uniform, and certain factors including ethnicity, gender, baseline HIV viral load and CD4+ T lymphocyte count, adherence and intravenous drug abuse are associated with different immunological, virological and clinical outcomes. Mental health illness (MHI) and specifically depression may be associated with worse outcomes, although studies exploring the impact of MHI on HIV outcomes in both the pre-HAART and post-HAART eras have shown mixed results. The objective of the current paper is to review the available literature on the impact of MHI on HIV outcomes in the HAART era.
引用
收藏
页码：246 / 255
页数：10
相关论文
共 90 条
[81]   Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy [J].
Starace, F ;
Ammassari, A ;
Trotta, MP ;
Murri, R ;
De Longis, P ;
Izzo, C ;
Scalzini, A ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S136-S139
[82]   Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study - Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study [J].
Starace, F ;
Bartoli, L ;
Aloisi, MS ;
Antinori, A ;
Narciso, P ;
Ippolito, G ;
Ravasio, L ;
Moioli, MC ;
Vangi, D ;
Gennero, L ;
Coronado, OV ;
Giacometti, A ;
Nappa, S ;
Perulli, ML ;
Montesarchio, V ;
La Gala, A ;
Ricci, F ;
Cristiano, L ;
De Marco, M ;
Izzo, C ;
Pezzotti, P ;
Monforte, AD .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (01) :20-26
[83]  
STERN Y, 1991, ARCH GEN PSYCHIAT, V48, P131
[84]  
Stoff DM, 2004, AIDS, V18, pS3, DOI 10.1097/00002030-200401001-00002
[85]   Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence. [J].
Stone V.E. .
Current HIV/AIDS Reports, 2005, 2 (4) :189-193
[86]   Psychotropic medications and HIV [J].
Thompson, A ;
Silverman, B ;
Dzeng, L ;
Treisman, G .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (09) :1305-1310
[87]   Disease progression in HIV-positive women with moderate to severe immunosuppression: The role of depression [J].
Vedhara, K ;
Schifitto, G ;
McDermott, M .
BEHAVIORAL MEDICINE, 1999, 25 (01) :43-47
[88]   Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression [J].
Walkup, James ;
Wei, Wenhui ;
Sambamoorthi, Usha ;
Crystal, Stephen .
PSYCHIATRIC QUARTERLY, 2008, 79 (01) :43-53
[89]   Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CC4 cell counts ≥ 200 cells/μl [J].
Wood, Evan ;
Hogg, Robert S. ;
Yip, Renita ;
Moore, David ;
Harrigan, P. Richard ;
Montaner, Julio S. G. .
AIDS, 2006, 20 (08) :1117-1123
[90]   Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients [J].
Yun, LWH ;
Maravi, M ;
Kobayashi, JS ;
Barton, PL ;
Davidson, AJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) :432-438
123456789